The myokine Decorin improves the cardiac function in a rat model of isoprenaline induced myocardial infarction

Myocardial infarction is a common cause of disability. Decorin is a myokine that has anti-inflammatory, anti-apoptotic effects. Some studies stated that decorin protects myocardium from ischemia. Other studies stated that decorin levels are associated with acute coronary syndrome. The study aimed is to investigate therapeutic role of Decorin on cardiac function in rat model of myocardial infarction. 30 adult male Wistar rats were divided into: Control group: rats were subcutaneously injected with normal saline. Isoprenaline injected group: rats were subcutaneously injected with isoprenaline (85 mg/kg) once daily for 2 days to induce myocardial infarction. Decorin +Isoprenaline injected group: rats were injected as the previous group, followed by Decorin injection (0.1/ mg/kg) once daily for 7 days. Cardiac hemodynamics, serum Lactate Dehydrogenase(LDH), CreatineKinase-MB(CK-MB), oxidative stress markers, gene expression for myocardial transforming growth factor beta 1 (TGF-β1), interleukin 1 b (IL1 b),tumor necrosis factor alpha (TNF), cardiac caspase3 immunohistochemical analysis were done. Isoprenaline+Decorin group had significant improvement in cardiac hemodynamics, oxidative stress markers, significant decrease in serum CK-MB, LDH, myocardial gene expression for TNF-alpha, IL-1B, TGF B1, decreased cardiac caspase-3 immunoreactivity was present. Therefore, Decorin can be used as a therapeutic agent after myocardial infarction as it improved the cardiac function.

Effect of fetuin-A on adenine-induced chronic kidney disease model in male rats

Objectives

This study aimed to investigate the possible effects of fetuin-A on an adenine-induced chronic kidney disease (CKD) model in male rats.

Materials and Methods

Rats were divided into three groups: group A included rats fed a normal diet; group B included rats fed a normal diet with 220 mg/kg adenine daily for 21 days; group C included rats fed a normal diet with 220 mg/kg adenine daily for 21 days and intraperitoneally administered with 5 mg\kg fetuin-A every other day for 2 weeks. Serum samples were assayed for serum creatinine, urea, sodium, potassium, calcium, phosphorus, tumor necrosis factor (TNF), interleukin-6 (IL-6), and estimated glomerular filtration rate (eGFR), and immunohistochemical staining was performed.

Results

Group B showed a significant increase in serum creatinine, urea, phosphorus, potassium, TNF, and IL-6 and a significant decrease in serum sodium, calcium, and eGFR compared with group A. Regarding immunohistochemistry, group B showed increased apoptosis. In group C, fetuin-A reduced the urea, creatinine, and phosphorus levels, and in group C, fetuin-A decreased inflammation and apoptosis by reduction of caspase-3 staining.

Conclusion

Fetuin-A improved kidney function in CKD due to its anti-inflammatory and anti-fibrotic role.